Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|June 23, 2019
Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathwayHongzhi Zhang, Huijuan Jiang, Huixiang Zhang, et al.
European Journal of Pharmacology|November 12, 2017
Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cellsHongzhi Zhang, Huijuan Jiang, Lei Chen, et al.
Oncotargets and Therapy|January 31, 2019
miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancerHongzhi Zhang, Huijuan Jiang, Huixiang Zhang, et al.
Environment International|July 16, 2025
Disentangling the Fe species-dependent electron donating capacity and abiotic reduction capacity towards nitrobenzene of the sediment coresHuixiang Zhang, Xin Li, Shanshan Yang, et al.
Aging|March 6, 2021
The impact of visceral obesity on chronic constipation, inflammation, immune function and cognitive function in patients with inflammatory bowel diseaseYemin Wan, Dan Zhang, Ting Xing, et al.
Ultrasonics Sonochemistry|June 15, 2023
Polymer-mediated and ultrasound-assisted crystallization of ropivacaine: Crystal growth and morphology modulationYan Wang, Huixiang Zhang, Lun Cai, et al.
BMC Psychiatry|September 6, 2024
Effectiveness of internet-based self-help interventions for depression in adolescents and young adults: a systematic review and meta-analysisQian Ma, Yimin Shi, Wei Zhao, et al.
International Immunopharmacology|February 15, 2025
IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/ PTGS2 pathwayHuixiang Zhang, Haohan Li, Yanyan Qi, et al.
Biomimetics (Basel, Switzerland)|August 25, 2023
Deep Learning in the Ubiquitous Human-Computer Interactive 6G Era: Applications, Principles and ProspectsChunlei Chen, Huixiang Zhang, Jinkui Hou, et al.
Molecular Therapy Oncolytics|December 2, 2022
A cross-reactive pH-dependent EGFR antibody with improved tumor selectivity and penetration obtained by structure-guided engineeringXiming Liu, Xinxin Tian, Xinyan Hao, et al.
Pageof 4